Interim Financial Information Individual and Consolidated

(A free translation of the original in Portuguese)

March 31, 2024

Interim Financial Information, Individual and Consolidated | March 31, 2024

Índex

Índex

2

Statements of Financial Position

4

Statements of Income (Loss)

5

Statements of Comprehensive Income (Loss)

6

Statements of Changes in Equity

7

Statements of Cash Flows

8

Statements of Value Added

9

Management Report

10

1.

Company's Operations

41

2.

Basis of preparation and presentation of interim financial information

43

3.

Summary of material accounting policies

44

4.

Cash and cash equivalents

45

5.

Marketable securities

45

6.

Trade accounts and notes receivable

46

7.

Inventories

47

8.

Biological assets

49

9.

Recoverable taxes

50

10.

Deferred income taxes

52

11.

Judicial deposits

54

12.

Investments

54

13.

Property, plant and equipment

56

14.

Intangible assets

58

15.

Loans and borrowings

60

16.

Trade accounts payable

62

2

Interim Financial Information, Individual and Consolidated | March 31, 2024

17.

Leases

63

18.

Share-based payment

65

19.

Employees benefits

66

20.

Provision for tax, civil and labor risks

66

21.

Equity

67

22.

Earnings (loss) per share

69

23.

Financial instruments and risk management

69

24.

Segment information

83

25.

Net sales

85

26.

Expenses by nature

86

27.

Financial income (expenses)

87

28.

Related parties

88

29.

Commitments

91

30.

Transactions that do not involve cash

91

31.

Events after the reporting period

92

32.

Approval of the Financial Statements

93

INDEPENDENT AUDITORS' REPORT ON INDIVIDUAL AND CONSOLIDATED INTERIM FINANCIAL

INFORMATION

95

Opinion of the Audit and Integrity Commitee

97

Statement of Executive Board on the Consolidated Interim Financial Information and Independent

Auditor's Report

98

3

Interim Financial Information, Individual and Consolidated | March 31, 2024

Statements of Financial Position

Parent company

Consolidated

Parent company

Consolidated

ASSETS

Note

03.31.24

12.31.23

03.31.24

12.31.23

LIABILITIES

Note

03.31.24

12.31.23

03.31.24

12.31.23

CURRENT ASSETS

CURRENT LIABILITIES

Cash and cash equivalents

4

4,523,944

4,701,549

9,567,208

9,264,664

Loans and borrowings

15

2,114,310

2,237,214

2,260,733

2,451,838

Marketable securities

5

422,925

412,107

469,515

447,878

Trade accounts payable

16

13,381,858

14,011,988

11,956,380

12,592,006

Trade receivables

6

4,276,970

5,655,967

4,281,896

4,766,071

Lease liability

17.2

881,319

835,154

1,043,159

944,326

Notes receivable

6

37,499

64,731

37,499

64,731

Payroll, related charges and employee profit sharing

993,405

886,974

1,095,629

984,457

Inventories

7

4,305,076

4,717,540

6,276,532

6,628,890

Taxes payable

205,333

316,600

742,892

585,129

Biological assets

8

2,662,080

2,580,383

2,795,193

2,702,164

Derivative financial instruments

23

48,299

74,112

49,284

76,940

Recoverable taxes

9

1,285,826

1,210,028

1,727,753

1,517,548

Provision for tax, civil and labor risks

20

706,369

717,119

709,492

720,187

Derivative financial instruments

23

31,818

109,222

31,818

109,222

Employee benefits

19

58,894

58,894

84,906

86,423

Prepaid expenses

296,370

126,557

341,097

166,230

Customer advances

10,030

6,320

344,610

290,279

Advances

61,621

64,677

130,067

123,319

Advances from related parties

28

5,771,640

6,119,677

1

-

Restricted cash

-

-

14,177

13,814

Other current liabilities

183,157

282,712

559,678

658,763

Assets held for sale

4,284

684

11,375

7,204

Other current assets

183,741

132,989

196,804

142,527

Total current assets

18,092,154

19,776,434

25,880,934

25,954,262

Total current liabilities

24,354,614

25,546,764

18,846,764

19,390,348

NON-CURRENT ASSETS

NON-CURRENT LIABILITIES

LONG-TERM RECEIVALBLES

Loans and borrowings

15

15,324,356

15,462,088

17,576,020

17,643,710

Marketable securities

5

18,237

16,490

272,244

319,995

Trade accounts payable

16

691

422

691

422

Trade receivables

6

5,943

5,897

7,882

5,897

Lease liability

17.2

2,750,426

2,624,979

2,989,942

2,777,521

Notes receivable

6

22,052

1,530

22,052

1,530

Taxes payable

85,459

88,211

87,737

90,669

Recoverable taxes

9

4,677,785

4,981,378

4,696,060

5,000,740

Provision for tax, civil and labor risks

20

431,420

442,621

470,940

482,983

Deferred income taxes

10

2,131,624

2,054,826

2,190,159

2,113,108

Deferred income taxes

10

-

-

70,716

60,125

Judicial deposits

11

405,734

405,450

416,647

415,718

Liabilities with related parties

28

53,308

52,581

-

-

Biological assets

8

1,776,517

1,788,383

1,860,790

1,858,316

Employee benefits

19

271,692

264,731

464,354

454,398

Derivative financial instruments

23

495,492

529,830

495,492

529,830

Derivative financial instruments

23

54,935

59,819

54,935

59,819

Restricted cash

31,732

30,952

74,262

72,395

Other non-current liabilities

320,793

286,982

651,267

668,439

Other non-current assets

168,878

148,262

174,359

153,052

Total long-term receivables

9,733,994

9,962,998

10,209,947

10,470,581

Total non-current liabilities

19,293,080

19,282,434

22,366,602

22,238,086

EQUITY

21

Capital

13,349,156

13,349,156

13,349,156

13,349,156

Capital reserves

2,763,364

2,763,364

2,763,364

2,763,364

Other equity transactions

(64,493)

(70,106)

(64,493)

(70,106)

Investments

12

14,654,950

13,683,725

95,249

97,895

Accumulated earnings

504,993

-

504,993

-

Property, plant and equipment

13

13,196,922

13,127,930

14,870,629

14,608,914

Treasury shares

(231,240)

(96,145)

(231,240)

(96,145)

Intangible assets

14

3,197,816

3,201,539

6,203,100

6,140,438

Other comprehensive loss

(1,093,638)

(1,022,841)

(1,093,638)

(1,022,841)

Attributable to controlling shareholders

15,228,142

14,923,428

15,228,142

14,923,428

Non-controlling interests

-

-

818,351

720,228

Total non-current assets

40,783,682

39,976,192

31,378,925

31,317,828

Total equity

15,228,142

14,923,428

16,046,493

15,643,656

TOTAL ASSETS

58,875,836

59,752,626

57,259,859

57,272,090

TOTAL LIABILITIES AND EQUITY

58,875,836

59,752,626

57,259,859

57,272,090

The accompanying notes are an integral part of the interim financial information.

(In thousands of Brazilian Reais)

4

Interim Financial Information, Individual and Consolidated | March 31, 2024

Statements of Income (Loss)

-

-

Parent company

Consolidated

2024

2023

2024

2023

Note

Jan - mar

Jan - mar

Jan - mar

Jan - mar

NET SALES

25

10,867,663

11,997,860

13,377,509

13,177,969

Cost of sales

26

(8,645,982)

(9,720,386)

(10,153,222)

(11,504,756)

GROSS PROFIT

2,221,681

2,277,474

3,224,287

1,673,213

OPERATING INCOME (EXPENSES)

Selling expenses

26

(1,523,767)

(1,584,564)

(1,771,818)

(1,770,641)

General and administrative expenses

26

(129,258)

(95,086)

(201,493)

(159,807)

Impairment loss on trade receivables

6

(15,920)

(5,545)

(27,218)

(6,507)

Other operating income (expenses), net

26

30,130

77,458

30,944

84,398

Income from associates and joint ventures

12

898,641

(1,023,781)

(2,407)

(17)

INCOME (LOSS) BEFORE FINANCIAL RESULTS AND INCOME TAXES

1,481,507

(354,044)

1,252,295

(179,361)

Financial income

196,746

157,563

274,679

198,130

Financial expenses

(931,482)

(1,058,307)

(907,113)

(1,036,189)

Foreign exchange and monetary variations

(252,604)

200,051

94,807

(22,012)

FINANCIAL INCOME (EXPENSES), NET

27

(987,340)

(700,693)

(537,627)

(860,071)

INCOME (LOSS) BEFORE TAXES

494,167

(1,054,737)

714,668

(1,039,432)

Income taxes

10

10,826

20,718

(120,924)

15,805

INCOME (LOSS) FOR THE YEAR

504,993

(1,034,019)

593,744

(1,023,627)

Income (Loss) Attributable to

Controlling shareholders

504,993

(1,034,019)

504,993

(1,034,019)

Non-controlling interest

-

-

88,751

10,392

504,993

(1,034,019)

593,744

(1,023,627)

INCOME (LOSS) PER SHARE

Weighted average shares outstanding - basic

1,670,951,834

1,078,116,849

Loss per share - basic

22

0.30

(0.96)

Weighted average shares outstanding - diluted

1,672,476,188

1,078,116,849

Income (Loss) per share - diluted

22

0.30

(0.96)

The accompanying notes are an integral part of the interim financial information.

(In thousands of Brazilian Reais)

5

Interim Financial Information, Individual and Consolidated | March 31, 2024

Statements of Comprehensive Income (Loss)

Note

Income (loss) for the period

Other comprehensive income (loss), net of taxes

Gain on foreign currency translation of foreign operations

Gain (loss) on net investment hedge (1)

Cash flow hedges - effective portion of changes in fair value (1)

Cash flow hedges - reclassified to profit or loss

23

Items that are or may be reclassified subsequently to profit or loss

Actuarial gains (losses) on pension and post-employment plans (1)

19

Items that will not be reclassified to profit or loss

Comprehensive income (loss) for the period

Attributable to

Controlling shareholders

Non-controlling interest

(1) Items above are stated net of deferred taxes on income and the related taxes are disclosed in note 10. The accompanying notes are an integral part of the interim financial information.

(In thousands of Brazilian Reais)

Parent company

Consolidated

2024

2023

2024

2023

Jan - mar

Jan - mar

Jan - mar

Jan - mar

504,993

(1,034,019)

593,744

(1,023,627)

67,575

28,113

85,156

56,469

(38,880)

52,942

(38,880)

52,942

(44,885)

1,251

(44,544)

8

(47,437)

(55,949)

(47,437)

(55,949)

(63,627)

26,357

(45,705)

53,470

(7,170)

2,995

(15,623)

862

(7,170)

2,995

(15,623)

862

434,196

(1,004,667)

532,416

(969,295)

434,196

(1,004,667)

434,196

(1,004,667)

-

-

98,220

35,372

434,196

(1,004,667)

532,416

(969,295)

6

Interim Financial Information, Individual and Consolidated | March 31, 2024

Statements of Changes in Equity

Attributed to controlling shareholders

Other comprehensive income (loss)

Accumulated

foreign

Gains

Total

currency

(losses) on

Actuarial

Accumulated

Non-

shareholders'

Capital

Other equity

Treasury

translation

cash flow

gains

aearnings

controlling

equity

Capital

reserves

transactions

shares

adjustments

hedge (1)

(losses)

(losses)

Total equity

interest

(consolidated)

BALANCES AT DECEMBER 31, 2022

12,835,915

2,338,476

(77,825)

(109,727)

(1,024,897)

(307,389)

(21,472)

(2,363,073)

11,270,008

552,861

11,822,869

Comprehensive income (loss) (1)

Losses on foreign currency translation of foreign operations

-

-

-

-

(169,326)

-

-

-

(169,326)

(139,739)

(309,065)

Gains on net investment hedge

-

-

-

-

145,328

-

-

-

145,328

-

145,328

Unrealized gains in cash flow hedge

-

-

-

-

-

372,958

-

-

372,958

418

373,376

Actuarial losses on pension and post-employment plans

-

-

-

-

-

-

(1,523)

-

(1,523)

(40,702)

(42,225)

Income (loss) for the year

-

-

-

-

-

-

-

(2,028,559)

(2,028,559)

159,707

(1,868,852)

SUB-TOTAL COMPREHENSIVE INCOME (LOSS)

-

-

-

-

(23,998)

372,958

(1,523)

(2,028,559)

(1,681,122)

(20,316)

(1,701,438)

Employee benefits remeasurement - defined benefit

-

-

-

-

-

-

(16,520)

16,520

-

-

-

Capital increase through issuance of shares

600,000

4,800,000

-

-

-

-

5,400,000

-

5,400,000

Expenses with public exchange offer of shares

(86,759)

-

-

-

-

-

-

(86,759)

-

(86,759)

Capital increase in subsidiaries

-

-

-

-

-

-

-

-

-

187,777

187,777

Appropriation of income (loss)

Dividends

-

-

-

-

-

-

-

-

-

(94)

(94)

Compensation of accumulated losses with capital reserve

-

(4,375,112)

-

-

-

-

4,375,112

-

-

-

Share-based payments

-

-

7,719

13,582

-

-

-

-

21,301

-

21,301

BALANCES AT DECEMBER 31, 2023

13,349,156

2,763,364

(70,106)

(96,145)

(1,048,895)

65,569

(39,515)

-

14,923,428

720,228

15,643,656

Comprehensive income (loss) (1)

Gain on foreign currency translation of foreign operations

-

-

-

-

67,575

-

-

-

67,575

17,581

85,156

Loss on net investment hedge

-

-

-

-

(38,880)

-

-

-

(38,880)

-

(38,880)

Unrealized gains (losses) in cash flow hedge

-

-

-

-

-

(92,322)

-

-

(92,322)

341

(91,981)

Actuarial losses on pension and post-employment plans

-

-

-

-

-

-

(7,170)

-

(7,170)

(8,453)

(15,623)

Income for the period

-

-

-

-

-

-

-

504,993

504,993

88,751

593,744

SUB-TOTAL COMPREHENSIVE INCOME (LOSS)

-

-

-

-

28,695

(92,322)

(7,170)

504,993

434,196

98,220

532,416

Appropriation of income (loss)

Dividends

-

-

-

-

-

-

-

-

-

(97)

(97)

Share-based payments

-

-

5,613

-

-

-

-

-

5,613

-

5,613

Acquisition of treasury shares

-

-

(135,095)

-

-

-

-

(135,095)

-

(135,095)

BALANCES AT MARÇO 31, 2024

13,349,156

2,763,364

(64,493)

(231,240)

(1,020,200)

(26,753)

(46,685)

504,993

15,228,142

818,351

16,046,493

  1. All changes in other comprehensive income are presented net of deferred taxes on profit, when applicable, are disclosed in note 10.

The accompanying notes are an integral part of the interim financial information.

(In thousands of Brazilian Reais)

7

Interim Financial Information, Individual and Consolidated | March 31, 2024

Statements of Cash Flows

Parent company

Consolidated

2024

2023

2024

2023

Jan - mar

Jan - mar

Jan - mar

Jan - mar

CASH FLOWS FROM OPERATING ACTIVITIES

Income (loss) from continuing operations

504,993

(1,034,019)

593,744

(1,023,627)

Adjustments for:

Depreciation and amortization

376,823

337,933

479,465

438,992

Depreciation and depletion of biological assets

335,242

319,344

368,066

344,703

Result on disposal of property, plant and equipments and intangible

(17,715)

(74,276)

(17,654)

(78,372)

Provision for tax, civil and labor risks

78,432

74,248

77,654

74,373

Income from investments under the equity method

(898,641)

1,023,781

2,407

17

Financial results, net

987,340

700,693

537,623

860,071

Deferred income tax

(10,623)

(20,718)

(6,934)

(20,191)

Short-term employee benefits

87,188

886

77,626

1,001

Other

13,033

15,458

19,149

30,940

1,456,072

1,343,330

2,131,146

627,907

Changes in assets and liabilities:

Trade accounts and notes receivables

1,406,005

1,226,287

633,198

548,105

Inventories

412,615

161,641

420,456

249,450

Biological assets - current

(81,697)

100,812

(97,633)

94,239

Trade accounts payable

(957,735)

(1,025,844)

(1,027,873)

(1,058,622)

Cash generated by operating activities

2,235,260

1,806,226

2,059,294

461,079

Redemptions (investments) in securities at FVTPL (1)

5,839

-

(47,740)

7,786

Interest received

83,426

65,299

209,655

91,786

Payment of tax, civil and labor provisions

(76,904)

(127,081)

(76,795)

(127,078)

Derivative financial instruments

(57,077)

(109,019)

(60,266)

(108,268)

Other operating assets and liabilities (2)

(689,052)

(151,243)

(162,489)

269,109

Net cash provided by operating activities

1,501,492

1,484,182

1,921,659

594,414

CASH FLOWS FROM INVESTING ACTIVITIES

Redemption (additions) on investments in securities at amortized cost

-

-

49,149

(17,325)

Additions to property, plant and equipment

(120,860)

(196,857)

(133,268)

(238,084)

Additions to biological assets - non-current

(323,309)

(338,094)

(353,242)

(369,070)

Proceeds from disposals of property, plant, equipments and investment

29,933

3,262

29,933

3,262

Additions to intangible

(40,572)

(48,364)

(40,896)

(49,187)

Capital increase in affiliates

-

(195)

-

(195)

Capital increase in subsidiaries

(10,000)

-

-

-

Net cash used in investing activities

(464,808)

(580,248)

(448,324)

(670,599)

CASH FLOWS FROM FINANCING ACTIVITIES

Proceeds from debt issuance

19,647

734,291

64,867

1,783,263

Repayment of debt

(404,307)

(171,732)

(491,439)

(435,704)

Payment of interest

(461,358)

(455,612)

(527,764)

(528,255)

Payment of interest derivatives - fair value hedge

(85,737)

(139,842)

(85,737)

(139,842)

Treasury shares acquisition

(135,094)

-

(135,094)

-

Payment of lease liabilities

(154,295)

(123,500)

(198,134)

(170,898)

Net cash provided (used in) by financing activities

(1,221,144)

(156,395)

(1,373,301)

508,564

Effect of exchange rate variation on cash and cash equivalents

6,855

177

202,510

(96,826)

Net increase (decrease) in cash and cash equivalents

(177,605)

747,716

302,544

335,553

Balance at the beginning of the period

4,701,549

3,984,071

9,264,664

8,130,929

Balance at the end of the period

4,523,944

4,731,787

9,567,208

8,466,482

  1. FVTPL: Fair Value Through Profit and Loss.
  2. In the Parent Company, contemplates mainly the effects of prepayments of exports with subsidiaries in the amount of R$(310,591) in the three-month period ended March 31, 2024 (R$50,718 in the same period of the previous year).

The accompanying notes are an integral part of the interim financial information.

(In thousands of Brazilian Reais)

8

Interim Financial Information, Individual and Consolidated | March 31, 2024

Statements of Value Added

Parent company

Consolidated

2024

2023

2024

2023

Jan-mar

Jan-mar

Jan-mar

Jan-mar

1

- REVENUES

12,091,469

13,226,804

14,668,848

14,510,691

Sales of goods and products

11,958,760

12,962,161

14,537,515

14,210,378

Other income

30,544

77,407

31,358

84,347

Revenue related to construction of own assets

118,085

192,781

127,193

222,473

Expected credit losses

(15,920)

(5,545)

(27,218)

(6,507)

2

- SUPPLIES ACQUIRED FROM THIRD PARTIES

(8,019,572)

(9,414,312)

(9,412,730)

(11,073,235)

Costs of goods sold

(6,778,089)

(7,992,831)

(8,062,617)

(9,563,444)

Materials, energy, third parties services and other

(1,241,633)

(1,417,033)

(1,355,240)

(1,489,884)

Reversal for inventories losses

150

(4,448)

5,127

(19,907)

3

- GROSS ADDED VALUE (1-2)

4,071,897

3,812,492

5,256,118

3,437,456

4

- DEPRECIATION AND AMORTIZATION

(712,065)

(657,277)

(847,531)

(783,695)

5

- NET ADDED VALUE (3-4)

3,359,832

3,155,215

4,408,587

2,653,761

6

- VALUE ADDED RECEIVED THROUGH TRANSFER

1,094,969

(866,167)

271,849

198,164

Income from associates and joint ventures

898,641

(1,023,781)

(2,407)

(17)

Financial income

196,746

157,563

274,674

198,130

Others

(418)

51

(418)

51

7

- ADDED VALUE TO BE DISTRIBUTED (5+6)

4,454,801

2,289,048

4,680,436

2,851,925

8

- DISTRIBUTION OF ADDED VALUE

4,454,801

2,289,048

4,680,436

2,851,925

Payroll

1,513,376

1,323,130

1,772,107

1,554,326

Salaries

1,030,183

953,313

1,256,717

1,157,787

Benefits

408,234

298,113

434,349

318,263

Government severance indemnity fund for employees

74,959

71,704

81,041

78,276

Taxes, Fees and Contributions

1,211,319

1,064,457

1,439,102

1,159,080

Federal

494,574

360,472

670,580

402,359

State

700,408

690,181

749,668

740,283

Municipal

16,337

13,804

18,854

16,438

Capital Remuneration from Third Parties

1,225,113

935,480

875,483

1,162,146

Interests, including exchange variation

1,193,521

875,277

822,124

1,078,784

Rents

31,592

60,203

53,359

83,362

Interest on Own-Capital

504,993

(1,034,019)

593,744

(1,023,627)

Income (loss) for the period

504,993

(1,034,019)

504,993

(1,034,019)

Non-controlling interest

-

-

88,751

10,392

The accompanying notes are an integral part of the interim financial information.

(In thousands of Brazilian Reais)

9

São Paulo, May 07th, 2024 - BRF S.A. (B3: BRFS3; NYSE: BRFS) - "BRF" or "Company" releases its results for the 1st quarter of 2024. The comments included here refer to results in Reais, in accordance with Brazilian corporate law and practices adopted in Brazil and in accordance with International Financial Reporting Standards (IFRS), which comparisons are based on the same periods of 2023 and/or prior's years, as indicated.

QUARTERLY FINANCIAL INDICATORS

NET

GROSS

GROSS

NET

REVENUE

PROFIT

MARGIN

INCOME

R$ 13,378

R$ 3,224

24.1%

(LOSS)

R$ 594

Million R$

Million R$

Million R$

13,178 Million in 1Q23

1,673 Million in 1Q23

12.7% in 1Q23

(1,024) Million in 1Q23

ADJUSTED

ADJUSTED

FREE CASH

NET LEVERAGE

EBITDA

EBITDA MARGIN

FLOW

R$ 2,117

15.8%

R$ 844

1.45x

Million R$

Million R$

607 Million in 1Q23

4.6% in 1Q23

(1,002) Million in 1Q23

3.35x in 1Q23

DEBT AVERAGE

MARKET

STOCK PRICES

ISSUED

TERM

CAP

SHARES

7.8

R$

US$

years

Billion

28.01

BRFS3 R$ 16.65

1,682,473,246

5.65

BRFS US$ 3.36

14,036,779

ON Shares / Treasury Shares

7.4 years no 1Q23

Base: 05/07/2024

Base: 05/07/2024

Base: 03/31/2024

CONFERENCE CALL

05/08/2024 - Wednesday - 9h00 US ET | 10h00 BRT

Access in: Click here

Relatório da

10

AdministraçãoManagement Report1T24| 1Q24

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

BRF SA published this content on 07 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 May 2024 23:31:06 UTC.